Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec).
Kindmark H, Janson ET, Gustavsson B, Eriksson C, Larsson G, Granberg D, Kozlowacki G, Skogseid B, Welin S, Oberg K, Eriksson B.
Kindmark H, et al. Among authors: oberg k.
Acta Oncol. 2010;49(1):100-1. doi: 10.3109/02841860902897707.
Acta Oncol. 2010.
PMID: 20100145
Clinical Trial.
No abstract available.